Stroke Volume| & Heart Failure
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Integration of Detailed Modules in a Core Model of Body Fluid Homeostasis and Blood Pressure Regulation
Integration of detailed modules in a core model of body fluid homeostasis and blood pressure regulation. Alfredo Hernández, Virginie Le Rolle, David Ojeda, Pierre Baconnier, Julie Fontecave-Jallon, François Guillaud, Thibault Grosse, Robert Moss, Patrick Hannaert, Randall Thomas To cite this version: Alfredo Hernández, Virginie Le Rolle, David Ojeda, Pierre Baconnier, Julie Fontecave-Jallon, et al.. Integration of detailed modules in a core model of body fluid homeostasis and blood pres- sure regulation.. Progress in Biophysics and Molecular Biology, Elsevier, 2011, 107 (1), pp.169-82. 10.1016/j.pbiomolbio.2011.06.008. inserm-00654821 HAL Id: inserm-00654821 https://www.hal.inserm.fr/inserm-00654821 Submitted on 27 Dec 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Integration of detailed modules in a core model of body fluid homeostasis and blood pressure regulation Alfredo I. Hernández1,2, Virginie Le Rolle1,2, David Ojeda1,2, Pierre Baconnier3, Julie Fontecave-Jallon3, François Guillaud4, Thibault Grosse5,6, Robert G. Moss5,6, Patrick Hannaert4, S. Randall Thomas5,6 1INSERM, U642, Rennes, F-35000, France; 2Université de Rennes 1, LTSI, Rennes, F-35000, France; 3 UJF-Grenoble 1 / CNRS / TIMC-IMAG UMR 5525 (Equipe PRETA), Grenoble, F-38041, France 4INSERM U927. -
Regulation of the Systemic Circulation*
CIRCULATORY PHYSIOLOGY SECTION 6: REGULATION OF THE SYSTEMIC CIRCULATION* Summary: This set of notes integrates what we have learned about vascular and cardiac function into a whole so that we can see how the entire circulation is regulated. These are very important concepts and their mastery will move you a long way towards a real understanding of the operation of the circulatory system. I. The Systemic Vascular System -- The influence of cardiac output on the partition of blood between the venous and arterial sides of the systemic circulation. A. Earlier we have indicated that at rest most of the blood in the systemic circulation is located in the venous side. This is in part due to the relatively high capacitance of the venous system when compared to the arterial system. This gives a reserve of blood that can be used when demands for respiratory gas circulation increase as in exercise. B. When there is no circulation (death or experimental interruption of the cardiac output), there is still a blood pressure in both the arterial and venous systems. 1. As we indicated earlier, this is due to the elastic forces stored in the walls of the vessels -- since in the absence of a hemorrhage the vessels contain enough fluid to increase their volume beyond resting volume, there must be a pressure even if the blood is not moving. 2. This low pressure is referred to as the mean circulatory pressure (Guyton) and for normal blood volumes is about 7mmHg (know this value). 3. Due to the greater compliance of the venous system, the greatest relative proportion of the total blood volume will reside in the venous system when operating at the mean circulatory pressure (i.e., when the heart is stopped). -
Ventricular End-Diastolic Volume (Ml)
Stroke Volume and Heart Failure Black/Blue: text. Red: very important. Green: Doctor’s notes. Pink: formulas. Yellow: numbers. Gray: notes and explanation. Physiology Team 436 – Cardiovascular Block Lecture 9 Lecture: If work is intended for initial studying. Review: If work is intended for revision. 1 Objectives Study Smart: focus on mutual topics. From the students’ guide: Explain how cardiac contractility affect stroke volume. Calculate CO using Fick’s principle equation. Explain pathophysiology of heart failure and differentiate between left and right failure. Explain how the pathophysiology associated with heart failure results in typical signs and symptoms. 2 Stroke Volume Stroke volume: is the volume of blood pumped (ejected) by each ventricle per beat (during each ventricular systole), and it is about 70-80 ml/beat. Factors Affecting It: 1- End diastolic volume (EDV) (Preload): • It is: the volume of blood present in each ventricle at the end of ventricular diastole. • Preload: load on the muscle in the relaxed state. Indices of left ventricular • Normal amount: 120-130 ml, can be increased during diastole preload: (filling of ventricles) to a volume of (120-130mL). 1- Left ventricle end diastolic • Applying preload to a muscle causes: volume Or pressure (LVEDV) 1- The muscle to stretch. 2- Right atrial pressure 2- The muscle to develop passive tension. More relaxation time, more filling, more volume. EDV Depends on: A- Filling time: the duration of ventricular diastole. B- Venous return: the rate of blood flow during ventricular diastole. 3 Stroke Volume and Factors Affecting it 1- End diastolic volume (EDV) 2- End systolic volume (ESV) (Residual): (Preload): It is: volume of blood present (that remains) in Mechanism: each ventricle at the end of ventricular systole. -
Market Analysis of Clinical Cardiology 2020
Interventional Cardiology Journal 2019 Market Analysis ISSN 2471-8157 Vol.5 No.3 Market Analysis of Clinical Cardiology 2020 Emily Professor of Epidemiology and Public Health at Australian National University Australian Capital Territory, Australia, E-mail: [email protected] Hilaris Conferences heartily invites you to the Clinical Target Audience Cardiology in San Fransisco, USA during October 26-27, 2020, • Directors of Hypertension or related Programs or to uncover your research ideas and work on heart heath, Associations cardiac diagnosis, and cardiac surgery comes under Clinical • Heads, Deans and Professors of Hypertension or Cardiology Cardiology research. Cardiology is a medical specialty and a departments branch of internal medicine concerned with treatment of • Scientists and Researchers organizers disorders of the heart and the blood vessels. Hilaris • Doctors Conferences is assuring Clinical Cardiology 2020 will provide • Medical Colleges you that international platform to explore your recent paper in • Writers front of renowned keynote speakers, delegates, CEOs, • Healthcare professionals Professors and Doctors. We are waiting to have you in San • Founders and Employees of the related companies Fransisco. • Clinical investigators • Hospitals and Health Services Market Analysis • Pharmaceutical companies • Training institutions Cardiovascular disease is the major cause of death across • Support organizers the globe. It estimated that for 17.3 million deaths in 2015 and • Data Management Companies is further anticipated to claim 23.6 million lives in 2030 • Cardiologists training and education (according to estimation by the World Health Organization). • Nurse and nursing education institutions The International Diabetes Federation has estimating that approximately 415 million people were diabetic in 2015 while the number is expected to increase 642 million worldwide by Related Companies/Industries 2040. -
The Ottawa Cardiovascular Centre Is Pleased Concept and Capacity
502-1355 Bank Street, Ottawa, ON K1H 8K7 T 613-738-1584 F 613-738-9097 E [email protected] The Ottawa Cardiovascular Centre is pleased to announce the expansion of our clinic in terms of concept and capacity RAPID ACCESS • SHORT WAIT LISTS • EXPANDED SERVICES We have hired two Physician Assistants to extend and enhance our services. We have added a second pediatric cardiologist. In addition, we now offer: EXPANDED NON-INVASIVE SERVICES: Nuclear Cardiology Imaging expanded with 2 state of the art CZT solid state cameras Echocardiography expanded with addition for rapid acquisition/lower radiation of 4 state of the art GE Vivid E 90 systems • Treadmill or persantine stress myocardial • No wait times perfusion imaging • Echo contrast enhances difficult imaging RAPID REFERRAL CLINIC: • Treadmill and bicycle stress Atrial fibrillation/anticoagulation, chest pain, echocardiography palpitation/syncope, shortness of breath, • Adult and pediatric echocardiography post ER visit Arrhythmia Detection: Real time wireless RESIDUAL RISK CLINIC: prospective monitoring for immediate Optimization of diabetes, dyslipidemia, arrhythmia detection and notification hypertension, post revascularization, • 2 day holter monitoring vascular risk reduction, LV function/HF • 3 day holter: retrospective quantitative CardioOncology, adult congenital HD, analysis (on site hook-up and mail out first responders/sports – ischaemic Mini Holter) risk assessment Please note that e-Referral is now available via the OCEAN e-Referral Healthmap 502-1355 Bank Street, Ottawa, -
Cardio Vascular Assessment in Vasoplegia Following Cardiac Surgery Kanishka Indraratna*
Review Article ISSN 2639-846X Anesthesia & Pain Research Cardio Vascular Assessment in Vasoplegia Following Cardiac Surgery Kanishka Indraratna* *Correspondence: Kanishka Indraratna, Sri Jayewardenepura General Hospital, Sri Sri Jayewardenepura General Hospital, Sri Lanka, Postal Address- Lanka, Postal Address-7A, Claessen Place, Colombo-5, Sri Lanka, 7A, Claessen Place, Colombo, Sri Lanka. Tel: +94777578144, E-mail: [email protected]. Received: 25 July 2018; Accepted: 29 August 2018 Citation: Indraratna K. Cardiovascular Assessment in Vasoplegia Following Cardiac Surgery. Anesth Pain Res. 2018; 2(2): 1-4. ABSTRACT Severe vasodilatation during cardiac surgery has been known for many years. It is characterized by a low systemic vascular resistance, a high cardiac index, and a low blood pressure, which can be resistant to even high doses of vasoconstrictors. This condition is associated with a high mortality. After cardiac surgery, there can be cardiac dysfunction as well. However with a low systemic vascular resistance, the cardiac function curve would be shifted upwards and to the left, giving the impression of good contractility. The ejection fraction, which is the commonly used measurement of cardiac contractility, cannot therefore be relied upon for a correct assessment under these circumstances. This can affect fluid and inotrope management. Therefore a measurement which does not depend on the afterload, but measures pure myocardial contractility is required. Ventricular elastance is such a measure. A measurement of arterial elastance which reflects the flow characteristics and pulsatility of flow may be more appropriate than systemic vascular resistance to measure arterial tone. Ventricular-arterial coupling has to be maintained for optimum myocardial performance. The severe vasodilatation, the possible myocardial impairment and also its treatment with high doses of vasoconstrictors can affect the relationship between the ventricular and arterial systems. -
Time-Varying Elastance and Left Ventricular Aortic Coupling Keith R
Walley Critical Care (2016) 20:270 DOI 10.1186/s13054-016-1439-6 REVIEW Open Access Left ventricular function: time-varying elastance and left ventricular aortic coupling Keith R. Walley Abstract heart must have special characteristics that allow it to respond appropriately and deliver necessary blood flow Many aspects of left ventricular function are explained and oxygen, even though flow is regulated from outside by considering ventricular pressure–volume characteristics. the heart. Contractility is best measured by the slope, Emax, of the To understand these special cardiac characteristics we end-systolic pressure–volume relationship. Ventricular start with ventricular function curves and show how systole is usefully characterized by a time-varying these curves are generated by underlying ventricular elastance (ΔP/ΔV). An extended area, the pressure– pressure–volume characteristics. Understanding ventricu- volume area, subtended by the ventricular pressure– lar function from a pressure–volume perspective leads to volume loop (useful mechanical work) and the ESPVR consideration of concepts such as time-varying ventricular (energy expended without mechanical work), is linearly elastance and the connection between the work of the related to myocardial oxygen consumption per beat. heart during a cardiac cycle and myocardial oxygen con- For energetically efficient systolic ejection ventricular sumption. Connection of the heart to the arterial circula- elastance should be, and is, matched to aortic elastance. tion is then considered. Diastole and the connection of Without matching, the fraction of energy expended the heart to the venous circulation is considered in an ab- without mechanical work increases and energy is lost breviated form as these relationships, which define how during ejection across the aortic valve. -
2.Heart As Pump
By Adam Hollingworth 2.Heart as a Pump Table of Contents Cardiac Cycle ......................................................................................................................................................... 2 CVS Pressures .................................................................................................................................................................... 3 Heart Failure ..................................................................................................................................................................... 3 Pericardium ....................................................................................................................................................................... 3 Timing .................................................................................................................................................................................. 4 Length of Systole & Diastole ......................................................................................................................................... 4 Arterial Pulse ........................................................................................................................................................ 4 JVP ............................................................................................................................................................................. 4 Cardiac Graph ...................................................................................................................................................... -
TRPA1 Is Essential for the Vascular Response to Environmental Cold Exposure
ARTICLE Received 18 Aug 2014 | Accepted 3 Nov 2014 | Published 11 Dec 2014 DOI: 10.1038/ncomms6732 OPEN TRPA1 is essential for the vascular response to environmental cold exposure Aisah A. Aubdool1, Rabea Graepel1, Xenia Kodji1, Khadija M. Alawi1, Jennifer V. Bodkin1, Salil Srivastava1, Clive Gentry2, Richard Heads1, Andrew D. Grant2, Elizabeth S. Fernandes1, Stuart Bevan2 & Susan D. Brain1 The cold-induced vascular response, consisting of vasoconstriction followed by vaso- dilatation, is critical for protecting the cutaneous tissues against cold injury. Whilst this physiological reflex response is historic knowledge, the mechanisms involved are unclear. Here by using a murine model of local environmental cold exposure, we show that TRPA1 acts as a primary vascular cold sensor, as determined through TRPA1 pharmacological antagonism or gene deletion. The initial cold-induced vasoconstriction is mediated via TRPA1-dependent superoxide production that stimulates a2C-adrenoceptors and Rho-kinase-mediated MLC phosphorylation, downstream of TRPA1 activation. The subsequent restorative blood flow component is also dependent on TRPA1 activation being mediated by sensory nerve-derived dilator neuropeptides CGRP and substance P, and also nNOS-derived NO. The results allow a new understanding of the importance of TRPA1 in cold exposure and provide impetus for further research into developing therapeutic agents aimed at the local protection of the skin in disease and adverse climates. 1 BHF Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, Cardiovascular Division, King’s College London, London SE1 9NH, UK. 2 Wolfson Centre for Age Related Diseases, King’s College London, London SE1 1UL, UK. Correspondence and requests for materials should be addressed to S.D.B. -
Cardiovascular Disease Prevention and Control Translating Evidence
Cardiovascular disease prevention and control Translating evidence into action 3 WHO Library Cataloguing-in-Publication Data Cardiovascular disease prevention and control: translating evidence into action. 1.Cardiovascular diseases - prevention and control 2.Cerebrovascular accident - prevention and control 3.Rheumatic heart disease - prevention and control 4.Risk reduction behavior I.World Health Organization. ISBN 92 4 159325 3 (NLM classification: WG 120) © World Health Organization 2005 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for per- mission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatso- ever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. -
Endogenously Released Adenosine Causes Pulmonary Vasodilation During the Acute Phase of Pulmonary Embolization in Dogs☆
IJC Heart & Vasculature 24 (2019) 100396 Contents lists available at ScienceDirect IJC Heart & Vasculature journal homepage: http://www.journals.elsevier.com/ijc-heart-and-vasculature Endogenously released adenosine causes pulmonary vasodilation during the acute phase of pulmonary embolization in dogs☆ Hiroko Takahama a,b,c, Hiroshi Asanuma d, Osamu Tsukamoto e,ShinItoa, Masafumi Kitakaze a,⁎ a Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan b Department of Cell Biology, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan c Department of Molecular Imaging in Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan d Department of Internal Medicine, Meiji University of Integrative Medicine, Hiyoshicho, Nantan, Kyoto, Japan e Department of Medical Biochemistry, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan article info abstract Article history: Background: Endogenous adenosine levels increase under stress in various organs. Exogenously administered Received 31 March 2019 adenosine is a well-known pulmonary vasodilator. However, the physiology and therapeutic potential of endog- Received in revised form 25 May 2019 enous adenosine during alteration in pulmonary hemodynamics such as pulmonary embolism is not elucidated. Accepted 24 June 2019 We hypothesized that the adenosine level increases following an acute elevation of pulmonary resistance, Available online 10 July 2019 resulting in pulmonary vasodilation. Methods: We induced acute pulmonary embolization by injecting plastic beads in anesthetized dogs. Plasma Keywords: adenosine levels, defined as the product of plasma adenosine concentration and simultaneous cardiac output, Adenosine Pulmonary embolization were assessed from blood samples from the superior vena cava, main pulmonary artery (MPA), and ascending Hemodynamics aorta 1 and 10 min following injection. -
Control of Cardiac Output in Thyrotoxic Calves. Evaluation of Changes in the Systemic Circulation
Control of cardiac output in thyrotoxic calves. Evaluation of changes in the systemic circulation. S Goldman, … , M Olajos, E Morkin J Clin Invest. 1984;73(2):358-365. https://doi.org/10.1172/JCI111220. Research Article The contribution of peripheral vascular factors to the high output state in thyrotoxicosis was examined in 11 calves treated with daily intramuscular injections of L-thyroxine (200 micrograms/kg) for 12-14 d. Thyroxine treatment increased cardiac output from 14.1 +/- 1.4 to 24.7 +/- 1.4 liters/min (P less than 0.001) and decreased systemic vascular resistance from 562 +/- 65 to 386 +/- 30 dyn-s/cm5 (P less than 0.01). Blood volume was increased from 65 +/- 4 ml/kg in the euthyroid state to 81 +/- 6 ml/kg when the animals were thyrotoxic (P less than 0.05). The role of low peripheral vascular resistance in maintenance of the high output state was evaluated by infusion of phenylephrine at two dosages (2.5 and 4.0 micrograms/kg per min). In the euthyroid state, no significant decrease in cardiac output was observed at either level of pressor infusion. In the thyrotoxic state, the higher dosage of phenylephrine increased peripheral resistance to the euthyroid control level and caused a small (6%) decrease in cardiac output (P less than 0.05). This small decrease in cardiac output probably could be attributed to the marked increase in left ventricular afterload caused by the pressor infusion as assessed from measurements of intraventricular pressure and dimensions. Changes in the venous circulation were evaluated by measurement of mean circulatory filling pressure and the pressure gradient […] Find the latest version: https://jci.me/111220/pdf Control of Cardiac Output in Thyrotoxic Calves Evaluation of Changes in the Systemic Circulation Steven Goldman, Marcey Olajos, and Eugene Morkin Department of Internal Medicine, Veterans Administration Medical Center, Tucson, Arizona 85723; Departments of Internal Medicine and Pharmacology, University ofArizona College of Medicine, Tucson, Arizona 85724 Abstract.